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Dr. Troyer is Senior Director and Neuroscience Leader in the Department of Clinical Pharmacology at 
Merck Research Laboratories. In this role, he is responsible for supervising the early clinical 
development of promising new treatments for neurological and psychiatric disorders. Matt works with 
basic and translational scientists during drug discovery and biomarker development to support novel 
therapeutic programs. In these roles, Matt has been fortunate to collaborate with a broad range of basic 
scientists, imaging experts, pharmacokineticists, modeling and simulation experts, clinicians and 
academics. Since joining Merck in 2005, Matt has also contributed to the clinical development of 
investigational drugs in the areas of diabetes, women's health, obesity and infectious disease. 
Prior to 2005, Matt was a member of the Neurology faculty at the University of California, San 
Francisco, and an attending neurologist in the Parkinson's Disease Clinic. At UCSF he also completed a 
postdoctoral fellowship in the laboratory of Robert Edwards where he studied vesicular neurotransmitter 
transporter function and mechanisms of neurodegeneration in Parkinson's disease. Dr. Troyer's clinical 
training includes a fellowship in Parkinson's disease and Movement Disorders at the Institute of 
NeurologylHuman Movement and Balance Unit, Queen Square, London, and residency at the Harvard­
Longwood Area Neurology program where he served as Chief Resident in 1995-1996. 
Matt received his medical education at Stanford University in 1992, and graduated from Illinois 
Wesleyan University with a major in Biology in 1986. His research interests are in the following areas: 
therapeutics in neurology and psychiatry, neurodegenerative diseases including Alzheimer's and 
Parkinson's diseases, translational medicine, novel clinical trial designs, central nervous system 
biomarker development, and model-based drug development. 
